Located in Ann Arbor, with a focus on providing evidence based care for people with severe mental illness, such as schizophrenia, bipolar disorder, obsessive-compulsive disorder and others. The main focus of the clinic is psychopharmacology and medication backup. Though the aim of our clinic is early treatment, any patient who may be in need of intensive outpatient care may be considered for treatment. In addition to an active clinic, the Early Treatment Center is also a site for clinical research trials. We conduct contract research for various pharmaceutical companies, including: Johnson & Johnson, Neurocrine, Otsuka, Astellas, Jansson, and a variety of others.